REQUEST A DEMO
Total
USD $0.00
Search more companies

Ucb Bulgaria EOOD (Bulgaria)

Main Activities: Marketing Research and Public Opinion Polling
Full name: Ucb Bulgaria EOOD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Ucb Bulgaria EOOD is a bio-pharmaceutical company with headquarters in Sophia, operating in about 40 countries. Founded with a focus on advanced research in biology and chemistry, the company specializes in severe diseases of the central nervous system and immunology. Ucb Bulgaria EOOD offers a range of products and therapies for conditions such as rheumatoid arthritis, epilepsy, and antihistamines for oral administration. The company is committed to providing access to quality care and medications for people with epilepsy in low and medium-income countries. Ucb Bulgaria EOOD has a presence in major pharmaceutical markets around the world and is focused on becoming a leading bio-pharmaceutical company of the next generation.

Headquarters
Ul. Srebarna 2b Et. 9 Ofis 8b
Sofia; Sofia - city; Postal Code: 1407

Contact Details: Purchase the Ucb Bulgaria EOOD report to view the information.

Website: http://www.ucb.bg

Basic Information
Total Employees:
Purchase the Ucb Bulgaria EOOD report to view the information.
Outstanding Shares:
Purchase the Ucb Bulgaria EOOD report to view the information.
Registered Capital:
Purchase the Ucb Bulgaria EOOD report to view the information.
Incorporation Date:
August 20, 2008
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ucb Bulgaria EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
20.51%
Total operating revenue
21.29%
Net Profit (Loss) for the Period
22.63%
Total assets
1.65%
Total equity
6.54%
Net Profit Margin
0.07%
Return on Equity (ROE)
1.44%
Quick Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?